This post was originally published on this site
Original post: Newswise - Drug and Drug Abuse Research team finds new dual benefit mode of action for a drug candidate to fight Covid-19
A research team led by Prof. Stephan Ludwig, a virologist at the Institute of Virology at the University of Munster, has found a new dual attack mode of action while working on the development of a drug candidate against SARS-CoV-2 infections.